Isolating Pathogen-Specific Human Monoclonal Antibodies (hmAbs) Using Bacterial Whole Cells as Molecular Probes
Attributed to:
Development of a cost-effective protein-based combined glycoconjugate meningococcal-pneumococcal vaccine
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/978-1-0716-0795-4_2
PubMed Identifier: 32959237
Publication URI: http://europepmc.org/abstract/MED/32959237
Type: Book Chapter
Book Title: Vaccine Delivery Technology - Methods and Protocols (2021)
Page Reference: 9-18
ISSN: 1064-3745